Page last updated: 2024-10-17

3-hydroxybutyric acid and Heart Diseases

3-hydroxybutyric acid has been researched along with Heart Diseases in 3 studies

3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.

Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.

Research Excerpts

ExcerptRelevanceReference
"Severe ketoacidosis induces heart failure and cardiac arrest, but its mechanism is unknown."1.38Inhibitory effect of β-hydroxybutyric acid on L-type Ca(2+) current under β-adrenergic stimulation in guinea pig cardiac ventricular myocytes. ( Akama, Y; Kimura, J; Kurihara, M, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Alfawara, MS2
Ahmed, AI2
Saad, JM2
Han, Y2
Alahdab, F2
Al Rifai, M2
Kassi, M2
Alnabelsi, T2
Zoghbi, WA2
Al-Mallah, MH2
Murano, C1
Binda, A1
Palestini, P1
Baruscotti, M1
DiFrancesco, JC1
Rivolta, I1
Kurihara, M1
Akama, Y1
Kimura, J1

Reviews

1 review available for 3-hydroxybutyric acid and Heart Diseases

ArticleYear
Effect of the ketogenic diet in excitable tissues.
    American journal of physiology. Cell physiology, 2021, 04-01, Volume: 320, Issue:4

    Topics: 3-Hydroxybutyric Acid; Animals; Central Nervous System Diseases; Diet, Ketogenic; Energy Metabolism;

2021

Other Studies

2 other studies available for 3-hydroxybutyric acid and Heart Diseases

ArticleYear
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:4

    Topics: 3-Hydroxybutyric Acid; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardium; Positron

2023
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:4

    Topics: 3-Hydroxybutyric Acid; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardium; Positron

2023
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:4

    Topics: 3-Hydroxybutyric Acid; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardium; Positron

2023
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:4

    Topics: 3-Hydroxybutyric Acid; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardium; Positron

2023
Inhibitory effect of β-hydroxybutyric acid on L-type Ca(2+) current under β-adrenergic stimulation in guinea pig cardiac ventricular myocytes.
    Fukushima journal of medical science, 2012, Volume: 58, Issue:2

    Topics: 3-Hydroxybutyric Acid; Adrenergic beta-Agonists; Animals; Calcium Channels, L-Type; GTP-Binding Prot

2012